Sysmex Corporation ADR (OTCMKTS:SSMXY) Short Interest Update

Key Points

• Sysmex Corporation saw a dramatic increase in short interest of 1,594.7% in September, rising from 11,300 shares to 191,500 shares by September 30th.
• The company reported a loss of $0.05 EPS for its last quarter, falling short of the expected $0.12 EPS, with revenue of $717.09 million compared to the forecast of $807.27 million.
• In recent analyst updates, Sysmex was upgraded from a "hold" to a "buy" rating by Goldman Sachs, and currently holds a consensus rating of "Moderate Buy".

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 191,500 shares, a growth of 1,594.7% from the September 15th total of 11,300 shares. Based on an average daily volume of 393,200 shares, the days-to-cover ratio is currently 0.5 days. Based on an average daily volume of 393,200 shares, the days-to-cover ratio is currently 0.5 days.

Sysmex Trading Up 1.0%

Sysmex stock traded up $0.12 during mid-day trading on Thursday, hitting $11.82. The stock had a trading volume of 1,317,212 shares, compared to its average volume of 118,148. The stock has a 50-day simple moving average of $12.81 and a two-hundred day simple moving average of $15.83. The stock has a market capitalization of $7.44 billion, a PE ratio of 23.64 and a beta of 1.16. Sysmex has a 12 month low of $11.66 and a 12 month high of $22.00. The company has a current ratio of 3.37, a quick ratio of 2.49 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.07). The firm had revenue of $717.09 million during the quarter, compared to the consensus estimate of $807.27 million. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. As a group, sell-side analysts forecast that Sysmex will post 0.57 EPS for the current year.

Analysts Set New Price Targets

SSMXY has been the subject of a number of recent research reports. Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. The Goldman Sachs Group upgraded Sysmex from a "hold" rating to a "buy" rating in a research note on Thursday, October 9th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, Sysmex currently has a consensus rating of "Moderate Buy".

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.